Nuchal translucency as a predictor of adverse pregnancy outcome
Authors:
- J. PiazzeJPJ. Piazze
- M.M. AnceschiMAM.M. Anceschi
- A. CerekjaACA. Cerekja
- R. La TorreRTR. La Torre
- A. PalaAPA. Pala
- A. PapaAPA. Papa
- E.V. CosmiECE.V. Cosmi
- 1 May 2007
- journal article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 98 (1) , 5-9
Abstract
Background Thickened nuchal translucency (NT) has been related to fetal genetic syndromes, structural abnormalities, and other diseases. The aim of this research was to evaluate the association of NT with adverse pregnancy outcomes. Study design In the period 2002–2004 in 2104 pregnant women between 10 + 6 and 13 + 5 weeks' gestation, NT was evaluated as a parameter for aneuploidy screening: out of these, 734 singleton pregnant women that underwent 2nd trimester amniocentesis and whose pregnancy outcome were known were selected. NT was statistically correlated to pregnancy and neonatal outcome. Results Median gestational age (GA) at NT evaluation was 11 + 2 weeks' gestation. NT median was 1.1 mm (0.9–1.4 mm, 25th–75th centile, range 0.5–4.0 mm). After multiple logistic regressions, the variables significantly associated to NT values were: threatened preterm labor (p < 0.008) and preterm labor (p < 0.02). The best diagnostic accuracy point was NT > 95th centile and > 1.5 MoM for the prediction of threatened preterm labor. Conclusion In this series, increased NT values were associated to threatened preterm labor and preterm labor in euploid fetuses: this finding may have clinical consequences in the management of such pregnancies.Keywords
This publication has 19 references indexed in Scilit:
- Increased nuchal translucency with normal karyotypeAmerican Journal of Obstetrics and Gynecology, 2005
- First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)American Journal of Obstetrics and Gynecology, 2004
- Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2004
- Association between fetal nuchal translucency thickness in first trimester and subsequent gestational hypertension and preeclampsiaPrenatal Diagnosis, 2002
- Increased fetal nuchal translucency at 11–14 weeksPrenatal Diagnosis, 2002
- Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetusesUltrasound in Obstetrics & Gynecology, 2001
- Screening for trisomy 13 by fetal nuchal translucency and maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestationPrenatal Diagnosis, 2000
- Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 1994
- The Prognostic Value of HCG, PAPP‐A, Oestradiol‐170 and Progesterone in Early Human PregnancyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1986
- Assay of a placental protein to determine fetal risk.BMJ, 1980